TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADRX
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – -107.2% –
– +21.8% +15.0% +2.1%
– -33.8% -27.0% +79.9%
– +20,091.4% -100.4% –
– +99.6% -92.2% +376.6%
– – -97.6% +200.0%
– +3,992.6% -105.3% –
– – -107.3% –

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?